| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8247796 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 8 Pages |
Abstract
Conclusion: Progression to MM remains the main problem. Patients with extramedullary SP had the best outcomes, especially when treated with moderate-dose RT. Chemotherapy and/or novel therapies should be investigated for bone or bulky extramedullary SP.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Mahmut M.D., Ph.D., Richard W. M.D., Philip M.D., Yazid M.D., Ph.D., Michel M.D., Fazilet M.D., Christine M.D., Bernard M.D., Jeroen M.D., Jürgen M.D., Sidney P. M.D., Anna M.D., Yavuz M.D., Josef M.D., Tan D. M.D., Gabriela M.D., Rachel M.D., Ph.D.,